Literature DB >> 9358553

Protection afforded by maltosyl-beta-cyclodextrin against alpha-chymotrypsin-catalyzed hydrolysis of a luteinizing hormone-releasing hormone agonist, buserelin acetate.

K Matsubara1, Y Ando, T Irie, K Uekama.   

Abstract

PURPOSE: The present study addresses how maltosyl-beta-cyclodextrin (G2-beta-CyD) impacts upon the alpha-chymotrypsin-catalyzed hydrolysis of buserelin acetate, an agonist of luteinizing hormone-releasing hormone with emphasis upon the direct effect of G2-beta-CyD on the activity of the protease.
METHODS: Kinetic and solubility studies were performed in isotonic phosphate buffer (pH 7.4) at 25 degrees C and 37 degrees C. The interaction of alpha-chymotrypsin with G2-beta-CyD in the buffer solution was examined by differential scanning calorimetry.
RESULTS: G2-beta-CyD decelerated the alpha-chymotrypsin-catalyzed hydrolysis of buserelin acetate to give the 1-3 tripeptide and the 4-9 hexapeptide fragments. This deceleration can be explained solely by a non-productive encounter between a complex of the substrate with G2-beta-CyD and the protease at relatively low CyD concentrations, while the direct inhibitory effect of G2-beta-CyD on the proteolytic activity made a considerable contribution to the overall deceleration of the hydrolysis at higher CyD concentrations. Calorimetric studies indicate the presence of intermediate states in the thermal unfolding of alpha-chymotrypsin, simultaneously accompanied by the autolysis. By contrast, a two-state thermal unfolding of alpha-chymotrypsin was observed in the presence of G2-beta-CyD, suggesting reduced proteolytic activity upon binding to G2-beta-CyD.
CONCLUSIONS: These results suggest that G2-beta-CyD at higher concentrations inhibits the proteolytic action of alpha-chymotrypsin through direct interaction with the protease, as well as through the formation of a non-productive complex with the substrate.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9358553     DOI: 10.1023/a:1012120705408

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

Review 1.  Buserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical profile.

Authors:  R N Brogden; M M Buckley; A Ward
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

2.  The adjuvant effect of bacitracin on nasal absorption of gonadorelin and buserelin in rats.

Authors:  S C Raehs; J Sandow; K Wirth; H P Merkle
Journal:  Pharm Res       Date:  1988-11       Impact factor: 4.200

3.  A thermodynamic approach to the problem of stabilization of globular protein structure: a calorimetric study.

Authors:  P L Privalov; N N Khechinashvili
Journal:  J Mol Biol       Date:  1974-07-05       Impact factor: 5.469

4.  The influence of the geometric properties of the active centre on the specificity of -chymotrypsin catalysis.

Authors:  V N Dorovska; S D Varfolomeyev; N F Kazanskaya; A A Klyosov; K Martinek
Journal:  FEBS Lett       Date:  1972-06-01       Impact factor: 4.124

5.  Ascidian sperm chymotrypsin-like enzyme; participation in fertilization.

Authors:  H Sawada; H Yokosawa; M Hoshi; S Ishii
Journal:  Experientia       Date:  1983-04-15

6.  Thermodynamics of the binding of Streptomyces subtilisin inhibitor to alpha-chymotrypsin.

Authors:  H Fukada; K Takahashi; J M Sturtevant
Journal:  Biochemistry       Date:  1985-09-10       Impact factor: 3.162

7.  Spectroscopic characterization of the inclusion complex of a luteinizing hormone-releasing hormone agonist, buserelin acetate, with dimethyl-beta-cyclodextrin.

Authors:  K Matsubara; T Irie; K Uekama
Journal:  Chem Pharm Bull (Tokyo)       Date:  1997-02       Impact factor: 1.645

8.  Increased thermal stability of proteins in the presence of sugars and polyols.

Authors:  J F Back; D Oakenfull; M B Smith
Journal:  Biochemistry       Date:  1979-11-13       Impact factor: 3.162

9.  The effect of cyclodextrins on the stability of peptides in nasal enzymic systems.

Authors:  W J Irwin; A K Dwivedi; P A Holbrook; M J Dey
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

10.  Improvement of nasal bioavailability of luteinizing hormone-releasing hormone agonist, buserelin, by cyclodextrin derivatives in rats.

Authors:  K Matsubara; K Abe; T Irie; K Uekama
Journal:  J Pharm Sci       Date:  1995-11       Impact factor: 3.534

  10 in total
  2 in total

1.  Effects of hydrophilic cyclodextrins on aggregation of recombinant human growth hormone.

Authors:  Sumitra Tavornvipas; Shinichiro Tajiri; Fumitoshi Hirayama; Hidetoshi Arima; Kaneto Uekama
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

2.  Preparation and characterization of β-cyclodextrin grafted N-maleoyl chitosan nanoparticles for drug delivery.

Authors:  Xinyu Hou; Wenjuan Zhang; Muye He; Yiben Lu; Kaiyan Lou; Feng Gao
Journal:  Asian J Pharm Sci       Date:  2017-07-25       Impact factor: 6.598

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.